Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085580 (
essential hypertension
)
14,686
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The purpose of this research was to obtain further information about the role of polymorphonuclear leukocytes in
essential hypertension
. These cells could be involved in the pathogenesis of organ injury. Thirty subjects (14 men and 16 women) with
essential hypertension
were enrolled. In these subjects we determined, at baseline and after in vitro activation with 4-phorbol 12-myristate 13-acetate and N:-formyl-methionyl-leucyl-phenylalanine, the polymorphonuclear leukocyte membrane fluidity, obtained by labeling the cells with 1-[4-(trimethylamino)phenyl]-6-phenyl-1,3, 5-hexatriene, cytosolic Ca(2+) concentration, obtained by marking the cells with Fura 2-AM, and integrin pattern (CD11a,
CD11b
, CD11c, and CD18), by using the indirect immunofluorescence with a flow cytometer. At baseline there was no difference in membrane fluidity between normal subjects and hypertensives, whereas hypertensives showed an increase in cytosolic Ca(2+) content and an increase of the phenotypical expression of CD11a,
CD11b
, and CD18. In normal subjects and in hypertensives, after activation, no variation was found in membrane fluidity and cytosolic Ca(2+) content. In normal subjects, after activation, we observed a significant increase of the expression of all adhesion molecules, whereas in hypertensives we found an increase of the expression of
CD11b
, CD11c, and CD18 but also a decrease of CD11a. The behavior of the polymorphonuclear leukocyte integrin profile may have several explanations, and in particular, the trend of CD11a after chemotactic activation may be related to its cleavage or to an altered integrin phosphorylation/dephosphorylation balance hypothetically present in this clinical condition.
...
PMID:Polymorphonuclear integrins, membrane fluidity, and cytosolic Ca(2+) content after activation in essential hypertension. 1108 48
In
essential hypertension
(
EHT
) the presence of a metabolic syndrome increases the risk of cardiovascular disease. A cell membrane abnormality is implicated but its role in cardiovascular disease is unclear. Neutrophil accumulation, which occurs by beta2-integrin (
CD11b
/CD18) expression, followed by release of proinflammatory factors from primary vesicles is an important factor in vascular damage.
CD11b
and CD69 expression on neutrophils from normal controls and
EHT
patients was determined by fluorescence-activated cell scanning. Neutrophils were activated with phorbol myristate acetate (PMA). Protein kinase C (PKC) and calpain were inhibited with bisindolylmaleimide and E64d, respectively. In
EHT
patients
CD11b
was not increased on neutrophils at rest. However,
EHT
neutrophils more readily expressed
CD11b
on incubation in phosphate-buffered saline and more cells went on to exocytose primary granules indicated by expression of CD69. Stimulation with PMA caused more rapid activation in
EHT
neutrophils with expression of
CD11b
, followed rapidly by exocytosis of primary granules. Bisindolylmaleimide slowed but did not prevent
CD11b
expression, which, together with primary granule exocytosis, continued to be faster in
EHT
neutrophils. E64d also slowed but did not prevent either
CD11b
expression or primary granule exocytosis, but this inhibitor did abolish the difference between NC and
EHT
neutrophils. The membrane abnormality in
EHT
may contribute to cardiovascular risk by increasing the rate of vesicle fusion with the cell membrane to increase neutrophil accumulation and release of inflammatory agents at sites of vascular damage. Calpain activation may be the rate-limiting component that is abnormal.
...
PMID:Rapid fusion of granules with neutrophil cell membranes in hypertensive patients may increase vascular damage. 1158 60